I wanted to ask 2 questions but I was driving. If anyone reaches out to Joe I’d like to know if GNBT directly benefits from any of the covid vaccine deals or only indirectly as majority owner of NGIO. For example is NGIO the developer and is GNBT handling the marketing and licensing and receiving “commissions” on the licensing deals.
Second question is does he fear at all licensing out the technology, particularly to China? Is there any protection against reverse engineering or copying the vaccine and dumping it illegally into markets they are not licensed for?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links